Brisbane [Australia], August 1 (ANI): Discovery of new cellular immunotherapy that targets a deadly type of head and neck cancer, caused by human papillomavirus (HPV), could lead to better survival rates, said Queensland scientists.
Brisbane [Australia], July 28 (ANI): Queensland scientists say the discovery of new cellular immunotherapy that targets a deadly type of head and neck cancer, caused by human papillomavirus (HPV), could lead to better survival rates.
Brisbane [Australia], Nov 20 (ANI): A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has found that it improved symptoms and quality of life for the majority of patients.